Quarterly report [Sections 13 or 15(d)]

Condensed Statement of Changes in Stockholders??? Equity (Unaudited)

v3.26.1
Condensed Statement of Changes in Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
At The Market Offering
Common Stock
Common Stock
At The Market Offering
Additional Paid-in Capital
Additional Paid-in Capital
At The Market Offering
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024     26,960,901        
Beginning balance at Dec. 31, 2024 $ 1,654   $ 3   $ 57,924   $ (56,273)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation expense 1,109       1,109    
Sale of Common Stock, net of issuance costs (in shares)     6,746,386        
Sale of Common Stock, net of issuance costs 10,250       10,250    
Stock issuance upon exercise of stock options (in shares)     27,261        
Stock issuance upon exercise of stock options 0       0    
Net loss (5,484)           (5,484)
Ending balance (in shares) at Mar. 31, 2025     33,734,548        
Ending balance at Mar. 31, 2025 $ 7,529   $ 3   69,283   (61,757)
Beginning balance (in shares) at Dec. 31, 2025 40,117,404   40,117,404        
Beginning balance at Dec. 31, 2025 $ 2,603   $ 4   79,887   (77,288)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation expense $ 1,217       1,217    
Sale of Common Stock, net of issuance costs (in shares)   970,467   970,467      
Sale of Common Stock, net of issuance costs   $ 1,515       $ 1,515  
Stock issuance upon exercise of stock options (in shares) 0            
Stock issuance upon vesting of restricted stock unit (in shares)     43,964        
Net loss $ (4,700)           (4,700)
Ending balance (in shares) at Mar. 31, 2026 41,131,835   41,131,835        
Ending balance at Mar. 31, 2026 $ 635   $ 4   $ 82,619   $ (81,988)